WaveMan · Form 4
Svoronos Dawn insider trades
> Search tickers & screens ⌘K
LIVE

Svoronos Dawn insider trades

Svoronos Dawn has filed 22 Form 4s with the SEC that we hold, for Xenon Pharmaceuticals Inc. (XENE) (Director), ADVM (Director), SLRN (Director) and GBT (Director), among 5 companies in all. Across all of them we count 2 purchases worth $295.5K and 4 sales worth $1.1M reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a sale of 25,000 shares of Xenon Pharmaceuticals Inc. worth $967.5K, dated 2023-08-24. The first filing on our record is dated 2022-01-11 and the latest 2026-09-03.

Xenon Pharmaceuticals Inc. (XENE)

Director · 7 filings · 1 purchase or sale
Trade dateCodeSharesValue as filedFiled
2023-08-24S, sale reported on Form 425,000$967.5K2023-08-24

ADVM

Director · 6 filings · 1 purchase or sale
Trade dateCodeSharesValue as filedFiled
2022-05-16P, purchase reported on Form 430,000$25.5K2022-05-18

SLRN

Director · 4 filings · 1 purchase or sale
Trade dateCodeSharesValue as filedFiled
2023-05-09P, purchase reported on Form 415,000$270.0K2023-05-11

GBT

Director · 3 filings · 1 purchase or sale
Trade dateCodeSharesValue as filedFiled
2022-06-21S, sale reported on Form 41,908$52.0K2022-06-22

Ptc Therapeutics, INC. (PTCT)

Director · 2 filings · 2 purchases and sales
Trade dateCodeSharesValue as filedFiled
2022-01-07S, sale reported on Form 4510$19.7K2022-01-11
2022-06-09S, sale reported on Form 4738$20.1K2022-06-10
Source

Counted from the Form 4 filings this reporting owner (SEC CIK 1574579) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.

Source: U.S. Securities and Exchange Commission (EDGAR) and other official government data · Updated 2026-10-12 · For informational purposes only, not investment advice.
Privacy · Terms